David K. Gaffney
Rating: 4.9 of 5
( out of 76 reviews )

David K. Gaffney, MD, PhD, FACR, FABS, FASTRO

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
1950 Circle of Hope
Salt Lake City , UT 84112
801-581-2396
Get Directions

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-581-2000
Get Directions

  • Senior Director for Clinical Research, Huntsman Cancer Institute

    Professor, Department of Radiation Oncology, University of Utah

    J Robert and Ann K Stewart Endowed Professorship

    David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology, Senior Director for Clinical Research, and J Robert and Ann K Stewart Endowed Professorship at the Huntsman Cancer Institute. His main research interests are in clinical trial development, prognostic markers, radiation sensitizers, and secondary cancers. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma.

    Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee and previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). He is a past chair of the American Brachytherapy Society and the Cervix Cancer Research Network. He is active in the Gynecologic Cancer Intergroup, a worldwide organization of clinical trial groups. He also chairs the Clinical Research Executive Committee at the Huntsman Cancer Institute and serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology, and Brachytherapy.

    In addition, Dr. Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.

    Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the University of Utah School of Medicine.

    Specialties

    Board Certification

    American Board of Radiology (Radiation Oncology)

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 76 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Gaffney is wonderful. Kind. Caring. Professional. A great doctor

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    good

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr. Gaffney provided me with the information I needed to make a decision about treatment. I feel confident that I will get excellent care as a result of my visit.

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Thank you Dr Gaffney. I know I am receiving the best care possible.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    He is a wonderful doctor.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Muy amable y profesional

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Excellent

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Doctor, nurse and resident Dr were all fantastic

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Thanks to the whole staff in the radiation oncology section of Huntsman. Everyone answered my questions and alleyed my fears of radiation...so far? !! Thanks so much.

  • Senior Director for Clinical Research, Huntsman Cancer Institute

    Professor, Department of Radiation Oncology, University of Utah

    J Robert and Ann K Stewart Endowed Professorship

    David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology, Senior Director for Clinical Research, and J Robert and Ann K Stewart Endowed Professorship at the Huntsman Cancer Institute. His main research interests are in clinical trial development, prognostic markers, radiation sensitizers, and secondary cancers. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma.

    Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee and previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). He is a past chair of the American Brachytherapy Society and the Cervix Cancer Research Network. He is active in the Gynecologic Cancer Intergroup, a worldwide organization of clinical trial groups. He also chairs the Clinical Research Executive Committee at the Huntsman Cancer Institute and serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology, and Brachytherapy.

    In addition, Dr. Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.

    Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the University of Utah School of Medicine.

    Board Certification and Academic Information

    Academic Departments Radiation Oncology -Professor
    Board Certification
    American Board of Radiology (Radiation Oncology)

    Education history

    Undergraduate Chemistry - University of Colorado B.A.
    Doctoral Training Biochemistry - Medical College of Wisconsin Ph.D.
    Professional Medical Medicine - Medical College of Wisconsin M.D.
    Internship LDS Hospital Intern
    Residency Radiation Oncology - University of Utah Resident

    Selected Publications

    Journal Article

    1. Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney D (2014). Impact of comorbid conditions on survival in endometrial cancer. American journal of clinical oncology, 37(2), 131-4. (Read full publication)
    2. Lum MM, Belnap TW, Frandsen J, Brown AP, Sause WT, Soisson AP, Dodson MK, Werner T, Gaffney D (2015). Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer. American journal of clinical oncology, 38(3), 283-8. (Read full publication)
    3. Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W Jr, Varia MA, Wahl AO, Yuh W, Gaffney D (2014). ACR appropriateness Criteria(R) advanced stage endometrial cancer. American journal of clinical oncology, 37(4), 391-6. (Read full publication)
    4. Odei B, Boothe D, Suneja G, Werner TL, Gaffney D (2018). Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival. American journal of clinical oncology, 41(8), 784-791. (Read full publication)
    5. Boothe D, Wolfson A, Christensen M, Francis S, Werner TL, Gaffney D (2019). Lymphovascular Invasion in Endometrial Cancer: Prognostic Value and Implications on Adjuvant Radiation Therapy Use. American journal of clinical oncology, 42(7), 549-554. (Read full publication)
    6. Ager BJ, Torgeson A, Francis SR, Burt LM, Gaffney DK, Cannon D (2020). Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation. American journal of clinical oncology, 43(1), 35-42. (Read full publication)
    7. Boothe D, Orton A, Kim J, Poppe MM, Werner TL, Gaffney D (2019). Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?. American journal of clinical oncology, 42(11), 813-817. (Read full publication)
    8. Parsons MW, Francis S, Maurer KA, Grant J, Gaffney D (2020). Refusal of Radiation Results in Inferior Survival in Endometrial Cancer. American journal of clinical oncology, 43(6), 399-410. (Read full publication)
    9. Lee CM, Salzman KL, Blumenthal DT, Gaffney D (2005). Intracranial extramedullary hematopoiesis: brief review of response to radiation therapy. American journal of hematology, 78(2), 151-2. (Read full publication)
    10. Ahmed F, Sarkar V, Gaffney DK, Salter B, Poppe M (2016). Analysis of nodal coverage utilizing image guided radiation therapy for primary gynecologic tumor volumes. Medical dosimetry, 41(3), 195-8. (Read full publication)
    11. Anker CJ, O'Donnell K, Boucher KM, Gaffney D (2013). Effect of brachytherapy technique and patient characteristics on cervical cancer implant dosimetry. . Medical dosimetry, 38(4), 430-5.
    12. Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W J (2015). ACR Appropriateness Criteria(R) Adjuvant Therapy in Vulvar Cancer. Oncology (Williston Park, N.Y.), 29(11), 867-72, 874-5. (Read full publication)
    13. Wagner AE, Wada D, Bowen G, Gaffney D (2013). Mycosis fungoides: the addition of concurrent and adjuvant interferon to total skin electron beam therapy. . The British journal of dermatology, 169(3), 715-8.
    14. Park J, Blackburn BE, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Burt L, Werner T, Gaffney DK, Lopez AM, Mooney K, Hashibe (2018). Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Annals of epidemiology, 28(6), 377-384. (Read full publication)
    15. Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney D (2015). NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer, 121(13), 2156-63. (Read full publication)
    16. Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR, Viswanathan AN, Gaffney D (2017). Cervical cancer: A global health crisis. Cancer, 123(13), 2404-2412. (Read full publication)
    17. Cooke EW, Pappas L, Gaffney D (2011). Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?. Cancer, 117(18), 4231-7. (Read full publication)
    18. Petru E, Lück HJ, Stuart G, Gaffney D, Millan D, Vergote (2009). Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. European journal of obstetrics, gynecology, and reproductive biology, 143(2), 69-74.
    19. Ly D, Rowley BD, Dodson MK, Soisson PA, Jolles CJ, Gaffney DK, Sause W (2014). Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival. Gynecologic oncology, 133(2), 250-5. (Read full publication)
    20. Chen LA, Kim J, Boucher K, Terakedis B, Williams B, Nickman NA, Gaffney D (2015). Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. Gynecologic oncology, 136(3), 521-8. (Read full publication)
    21. Ly D, Soisson PA, Dodson MK, Sause WT, Gaffney D (2015). Adjuvant radiation therapy is associated with improved pelvic control and overall survival in FIGO IB endometrial carcinoma with high grade histology. Gynecologic oncology, 138(3), 526-31. (Read full publication)
    22. Orton A, Boothe D, Williams N, Buchmiller T, Huang YJ, Suneja G, Poppe M, Gaffney (2016). Brachytherapy improves survival in primary vaginal cancer. Gynecologic oncology, 141(3), 501-506. (Read full publication)
    23. Soisson S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Hanson HA, Wu YP, Stanford J, Werner TL, Setiawan VW, Hashibe (2018). Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study. Gynecologic oncology, 148(3), 499-506. (Read full publication)
    24. Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner T (2018). Too many women are dying from cervix cancer: Problems and solutions. Gynecologic oncology, 151(3), 547-554. (Read full publication)
    25. Gil KM, Pugh SL, Klopp AH, Yeung AR, Wenzel L, Westin SN, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Kachnic LA, Bruner D (2019). Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy. Gynecologic oncology, 154(1), 183-188. (Read full publication)
    26. Francis SR, Ager BJ, Do OA, Huang YJ, Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD, Gaffney D (2019). Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy. Gynecologic oncology, 154(1), 38-44. (Read full publication)
    27. Ghia AJ, Neeley ES, Gaffney D (2010). Postoperative radiotherapy use and patterns of care analysis for node positive or parametria positive cervical cancer. Gynecologic oncology, 119(3), 411-6. (Read full publication)
    28. McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney D (2020). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecologic oncology, 156(1), 85-92. (Read full publication)
    29. Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney (2020). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT?. Gynecologic oncology, 156(1), 243-250. (Read full publication)
    30. Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK, Jhingran A, Klopp AH, Small W Jr, Yashar CM, Viswanathan A (2020). Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations. Gynecologic oncology, 158(2), 244-253. (Read full publication)
    31. Elshaikh MA, Modh A, Jhingran A, Biagioli MC, Coleman RL, Gaffney DK, Harkenrider MM, Heskett K, Jolly S, Kidd E, Lee LJ, Li L, Portelance L, Sherertz T, Venkatessan AM, Wahl AO, Yashar CM, Small W J (2020). Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma. Gynecologic oncology, 158(2), 460-466. (Read full publication)
    32. Kim S, Park J, Chen Y, Rowe K, Snyder J, Fraser A, Smith K, Deshmukh VG, Newman M, Herget K, Porucznik CA, Ose D, Playdon M, Gaffney D, Hashibe (2020). Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study. Gynecologic oncology, 156(1), 185-193. (Read full publication)
    33. Torgeson A, Boothe D, Poppe MM, Suneja G, Gaffney D (2017). Disparities in care for elderly women with endometrial cancer adversely effects survival. Gynecologic oncology, 147(2), 320-328.
    34. Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch (2014). Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. International journal of radiation oncology, biology, physics, 90(2), 320-8. (Read full publication)
    35. Gaffney DK, Suneja G, Ryu SY, McCormick M, Plante M, Mileshkin L, Small W Jr, Bacon M, Stuart G, Kitchener (2015). The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup. International journal of radiation oncology, biology, physics, 92(3), 506-8. (Read full publication)
    36. Frandsen J, Ly D, Cannon G, Suneja G, Matsen C, Gaffney DK, Wright M, Kokeny KE, Poppe M (2015). In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. International journal of radiation oncology, biology, physics, 93(5), 1096-103. (Read full publication)
    37. Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W Jr, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch (2016). Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. International journal of radiation oncology, biology, physics, 95(4), 1191-200. (Read full publication)
    38. Harkenrider MM, Martin B, Nieto K, Small C, Aref I, Bergman D, Chundury A, Elshaikh MA, Gaffney D, Jhingran A, Lee L, Paydar I, Ra K, Schwarz J, Thorpe C, Viswanathan AN, Small W J (2018). Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma. International journal of radiation oncology, biology, physics, 101(5), 1069-1077. (Read full publication)
    39. Patton GA, Gaffney DK, Moeller J (2003). Facilitation of radiotherapeutic error by computerized record and verify systems. International journal of radiation oncology, biology, physics, 56(1), 50-7. (Read full publication)
    40. Small W Jr, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney D (2021). NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. International journal of radiation oncology, biology, physics, 109(2), 413-424. (Read full publication)
    41. Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Sause W, Gaffney (2014). RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma. International journal of radiation oncology, biology, physics, 88(1), 101-5.
    42. Gay HA, Barthold HJ, O'Meara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W Jr, Gaffney D, Viswanathan AN, Michalski J (2012). Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. International journal of radiation oncology, biology, physics, 83(3), e353-62.
    43. Lim K, Small W Jr, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles (2011). Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. International journal of radiation oncology, biology, physics, 79(2), 348-55.
    44. Soisson S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Hanson HA, Wu YP, Stanford J, Al-Sarray A, Werner TL, Setiawan VW, Hashibe (2018). Long-term Cardiovascular Outcomes Among Endometrial Cancer Survivors in a Large, Population-Based Cohort Study. Journal of the National Cancer Institute, 110(12), 1342-1351. (Read full publication)
    45. Khan AJ, Poppe MM, Goyal S, Kokeny KE, Kearney T, Kirstein L, Toppmeyer D, Moore DF, Chen C, Gaffney DK, Haffty B (2017). Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial. Journal of clinical oncology, 35(18), 2037-2043. (Read full publication)
    46. Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner D (2018). Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. Journal of clinical oncology, 36(24), 2538-2544. (Read full publication)
    47. Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Bruner DW, Kachnic L (2020). Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study. Journal of clinical oncology, 38(15), 1685-1692. (Read full publication)
    48. Zhao H, Williams N, Poppe M, Sarkar V, Wang B, Rassiah-Szegedi P, Huang YJ, Kokeny K, Gaffney D, Salter (2019). Comparison of surface guidance and target matching for image-guided accelerated partial breast irradiation (APBI). Medical physics, 46(11), 4717-4724. (Read full publication)
    49. Lee CM, Fuhrman CB, Planelles V, Peltier MR, Gaffney DK, Soisson AP, Dodson MK, Tolley HD, Green CL, Zempolich K (2006). Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clinical cancer research, 12(1), 250-6. (Read full publication)
    50. Weidhaas JB, Li SX, Winter K, Ryu J, Jhingran A, Miller B, Dicker AP, Gaffney (2009). Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128. Clinical cancer research, 15(12), 4199-206. (Read full publication)
    51. Cho S, Sun Y, Jarboe EA, Soisson AP, Dodson MK, Gaffney DK, Peterson CM, Janát-Amsbury M (2013). Mucoadhesive hybrid gel improves intraperitoneal platinum delivery. International journal of pharmaceutics, 458(1), 148-55. (Read full publication)
    52. Williams NL, Werner TL, Jarboe EA, Gaffney D (2015). Adenocarcinoma of the cervix: should we treat it differently?. Current oncology reports, 17(4), 17. (Read full publication)
    53. Blackburn BE, Soisson S, Rowe K, Snyder J, Fraser A, Deshmukh V, Newman M, Smith K, Herget K, Kirchhoff AC, Kepka D, Werner TL, Gaffney D, Mooney K, Hashibe (2019). Prognostic factors for rural endometrial cancer patients in a population-based cohort. BMC public health, 19(1), 921. (Read full publication)
    54. Gaffney DK, Jhingran A, Portelance L, Viswanathan A, Schefter T, Weidhaas J, Small W J (2014). Radiation therapy oncology group gynecologic oncology working group: comprehensive results. International journal of gynecological cancer, 24(5), 956-62. (Read full publication)
    55. Bagshaw HP, Pappas LM, Kepka DL, Tward JD, Gaffney D (2014). Patterns of care with brachytherapy for cervical cancer. International journal of gynecological cancer, 24(9), 1659-64. (Read full publication)
    56. Small W Jr, Peltecu G, Puiu A, Corha A, Cocîr¿¿ E, Cig'ran RG, Plante M, Jhingran A, Stang K, Gaffney D, Bacon M, McCormack (2020). Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference. International journal of gynecological cancer, 31, 1061-1067. (Read full publication)
    57. Frandsen JE, Cannon G, Kokeny KE, Gaffney DK, Matsen C, Wright M, Poppe M (2018). Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review. The breast journal, 24(1), 7-11. (Read full publication)
    58. Frandsen J, Cannon G, Kokeny KE, Gaffney DK, Wright M, Pena K, Poppe M (2017). Post-mastectomy Radiotherapy for pT3N0 Breast Cancers: A Retrospective, Multi-Institution Review. The breast journal, 23(4), 452-455.
    59. Lalwani N, Dubinsky T, Javitt MC, Gaffney DK, Glanc P, Elshaikh MA, Kim YB, Lee LJ, Pannu HK, Royal HD, Shipp TD, Siegel CL, Simpson L, Wahl AO, Wolfson AH, Zelop CM, American College of Radiology (2014). ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer. Ultrasound quarterly, 30(1), 21-8. (Read full publication)
    60. Burt LM, Ying J, Poppe MM, Suneja G, Gaffney D (2017). Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. Breast (Edinburgh, Scotland), 35, 122-129. (Read full publication)
    61. Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp A, Small W Jr, Thomadsen B, Yashar C, Viswanathan (2015). Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy, 14(5), 587-99. (Read full publication)
    62. Sharma DN, Gaffney D (2016). Concurrent chemobrachytherapy in locally advanced cervical carcinoma: A hypothesis worth exploring. Brachytherapy, 15(2), 200-4. (Read full publication)
    63. Huang YJ, Su FF, Gaffney DK, Kokeny KE, Zhao H, Rassiah-Szegedi P, Salter BJ, Poppe M (2018). Skin dose estimation using virtual structures for Contura Multi-Lumen Balloon breast brachytherapy. Brachytherapy, 17(6), 956-965. (Read full publication)
    64. Ager BJ, Francis SR, Do OA, Huang YJ, Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD, Gaffney D (2019). Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?. Brachytherapy, 18(4), 453-461. (Read full publication)
    65. Sturdza A, Viswanathan AN, Erickson B, Yashar C, Bruggeman A, Feddock J, Klopp A, Beriwal S, Gaffney D, Han K, Kamrava (2020). American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers. Brachytherapy, 19(2), 127-138. (Read full publication)
    66. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, Dupont N, Eifel PJ, Fader AN, Fisher CM, Gaffney DK, George S, Han E, Huh WK, Lurain JR 3rd, Martin L, Mutch D, Remmenga SW, Reynolds RK, Small W Jr, Teng N, Tillmanns T, Valea FA, McMillian N, Hughes (2014). Uterine neoplasms, version 1.2014. Journal of the National Comprehensive Cancer Network, 12(2), 248-80. (Read full publication)
    67. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR 3rd, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Teng N, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone J (2015). Cervical Cancer, Version 2.2015. Journal of the National Comprehensive Cancer Network, 13(4), 395-404; quiz 404. (Read full publication)
    68. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL, National Comprehensive Cancer Network (2015). Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network, 13(11), 1321-31. (Read full publication)
    69. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone J (2018). Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 16(2), 170-199. (Read full publication)
    70. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone J (2019). Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 17(1), 64-84. (Read full publication)
    71. Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Wyse E, McMillian NR, Scavone (2019). Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 17(11), 1374-1391. (Read full publication)
    72. Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Huh WK, Lurain Iii JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Urban R, Wyse E, McMillian NR, Motter A (2020). NCCN Guidelines Insights: Cervical Cancer, Version 1.2020. Journal of the National Comprehensive Cancer Network, 18(6), 660-666. (Read full publication)
    73. Lee LJ, Ratner E, Uduman M, Winter K, Boeke M, Greven KM, King S, Burke TW, Underhill K, Kim H, Boulware RJ, Yu H, Parkash V, Lu L, Gaffney D, Dicker AP, Weidhaas (2014). The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. PloS one, 9(4), e94167. (Read full publication)
    74. Frandsen JE, Sause WT, Dodson MK, Soisson AP, Belnap TW, Gaffney D (2014). Survival analysis of endometrial cancer patients with cervical stromal involvement. Journal of gynecologic oncology, 25(2), 105-10. (Read full publication)
    75. Berek JS, Matsuo K, Grubbs BH, Gaffney DK, Lee SI, Kilcoyne A, Cheon GJ, Yoo CW, Li L, Shao Y, Chen T, Kim M, Mikami (2019). Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri. Journal of gynecologic oncology, 30(2), e40. (Read full publication)
    76. Odei B, Boothe D, Frandsen J, Poppe MM, Gaffney D (2017). The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma. Clinical lymphoma, myeloma & leukemia, 17(12), 819-824. (Read full publication)
    77. Frandsen J, Boothe D, Gaffney DK, Wilson BD, Lloyd (2015). Increased risk of death due to heart disease after radiotherapy for esophageal cancer. Journal of gastrointestinal oncology, 6(5), 516-23. (Read full publication)
    78. Tao R, Ager B, Lloyd S, Torgeson A, Denney M, Gaffney D, Kharofa J, Lin SH, Koong AC, Anzai Y, Hoffman J (2018). Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy. Journal of gastrointestinal oncology, 9(6), 1044-1053. (Read full publication)
    79. Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles (2015). Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. Practical radiation oncology, 5(6), e557-65. (Read full publication)
    80. Suneja G, Bacon M, Small W Jr, Ryu SY, Kitchener HC, Gaffney D (2015). The cervix cancer research network: increasing access to cancer clinical trials in low- and middle-income countries. Frontiers in oncology, 5, 14. (Read full publication)
    81. Hendrickson PG, Luo Y, Kohlmann W, Schiffman J, Maese L, Bishop AJ, Lloyd S, Kokeny KE, Hitchcock YJ, Poppe MM, Gaffney DK, Tao (2020). Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study. Cancer medicine, 9(21), 7954-7963. (Read full publication)
    82. Ager BJ, Gallardo-Rincón D, de León DC, Chávez-Blanco A, Chuang L, Dueñas-González A, Gómez-García E, Jerez R, Jhingran A, McCormack M, Mileshkin L, Pérez-Plasencia C, Plante M, Poveda A, Gaffney D (2018). Advancing clinical research globally: Cervical cancer research network from Mexico. Gynecologic oncology reports, 25, 90-93. (Read full publication)
    83. Olpin J, Chuang L, Berek J, Gaffney (2018). Imaging and cancer of the cervix in low- and middle-income countries. Gynecologic oncology reports, 25, 115-121. (Read full publication)
    84. Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, Scott AA, Anorlu RI, Sharma V, Plante M, Nyongesa C, Tigeneh W, Fakie N, Suneja G, Gaffney D (2021). Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management. JCO global oncology, 7, 173-182. (Read full publication)
    85. Nickman NA, Ye X, Gaffney DK, Barney RB, Biskupiak JE, Okano GJ, Lee VC, Arellano (2015). Cost of palliative external beam radiotherapy (EBRT) use for bone metastases secondary to prostate cancer. 13(3), 95-103. (Read full publication)
    86. Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Diver E, Fisher CM, Frederick P, Gaffney DK, George S, Giuntoli R, Han E, Howitt B, Huh WK, Lea J, Mariani A, Mutch D, Nekhlyudov L, Podoll M, Remmenga SW, Reynolds RK, Salani R, Sisodia R, Soliman P, Tanner E, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Motter A (2021). NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. Journal of the National Comprehensive Cancer Network, 19(8), 888-895. (Read full publication)
    87. Straubhar AM, Parsons MW, Francis S, Gaffney D, Maurer K (2021). Refusal of surgery and survival outcomes in endometrial cancer. International journal of gynecological cancer, 31(9), 1236-1241. (Read full publication)
    88. Holcombe RF, Verschraegen CF, Chapman AE, Gaffney D, Goldberg RM, Mesa RA, Milhem M, Mims M, Mitchell EP, Mulkerin D, Vijayakumar (2021). Status of the Clinician Investigator in America: An Essential Healthcare Provider Driving Advances in Cancer Care. Journal of the National Comprehensive Cancer Network, 19(2), 122-125. (Read full publication)
    89. Weil CR, Parsons MJ, Hutten RJ, Lew FH, Johnson SB, Gaffney DK, Tao (2022). Patterns of care and outcomes of early stage I-II Hodgkin lymphoma treated with or without radiation therapy. Leukemia & lymphoma, 63(12), 1-11. (Read full publication)
    90. Parsons MW, Wada DA, Halwani AS, Tao R, Gaffney D (2022). Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study. Leukemia & lymphoma, 63(10), 1-8. (Read full publication)
    91. Hutten RJ, Weil CR, Gaffney DK, Kokeny K, Lloyd S, Rogers CR, Suneja (2022). Worsening Racial Disparities in Utilization of Intensity Modulated Radiation Therapy. Advances in radiation oncology, 7(3), 100887. (Read full publication)
    92. Hutten RJ,Weil CR,Gaffney DK,Kokeny K,Lloyd S,Rogers CR,Suneja (2022). Racial and Ethnic Health Disparities in Delay to Initiation of Intensity-Modulated Radiotherapy. JCO oncology practice, 18(10), e1694-e1703. (Read full publication)
    93. Tao R,Chen Y,Kim S,Ocier K,Lloyd S,Poppe MM,Lee CJ,Glenn MJ,Smith KR,Fraser A,Deshmukh V,Newman MG,Snyder J,Rowe KG,Gaffney DK,Haaland B,Hashibe (2022). Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer, 128(19), 3564-3572. (Read full publication)
    94. Dood R,Trabert B,Werner TL,Gaffney D,Jarboe (2022). The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers. International journal of gynecological cancer, 32(8), 1087-1088. (Read full publication)
    95. Hutten RJ,Fenlon JB,Kessel AC,Straessler KM,Huang YJ,Gaffney DK,Suneja G,Zempolich K,Burt L (2022). Radical trachelectomy and adjuvant vaginal brachytherapy to preserve fertility in pediatric cervical adenocarcinoma. Brachytherapy, epub ahead of print, (Read full publication)
    96. Parsons MW,Rock C,Chipman JJ,Shah HR,Hu B,Stephens DM,Tao R,Tward JD,Gaffney D (2022). Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality. Cancer medicine, (Read full publication)
    97. Hu Q,Chang CP,Rowe K,Snyder J,Deshmukh V,Newman M,Fraser A,Smith K,Gren LH,Porucznik C,Stanford JB,Gaffney D,Henry NL,Lopez I,Hashibe (2021). Disparities in Cardiovascular Disease Risk among Hispanic Breast Cancer Survivors in a Population-Based Cohort. JNCI cancer spectrum, 5(2), (Read full publication)
    98. Chang CP,Chen Y,Blackburn B,Abdelaziz S,Rowe K,Snyder J,Dodson M,Deshmukh V,Newman M,Stanford JB,Porucznik CA,Ose J,Fraser A,Smith K,Doherty J,Gaffney D,Hashibe (2020). Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study. Gynecologic oncology, 157(2), 529-535. (Read full publication)
    99. Gaffney DK,Hashibe M,Kepka D,Maurer KA,Werner T (2019). Too many women are dying from cervix cancer: Problems and solutions. Obstetrical & gynecological survey, 74(3), 154-156. (Read full publication)
    100. Bookman MA,Okamoto A,Stuart G,Yanaihara N,Aoki D,Bacon M,Fujiwara K,González-Martín A,Harter P,Kim JW,Ledermann J,Pujade-Lauraine E,Quinn M,Ochiai K,Zeimet A,Marth C,du Bois A,Hilpert F,Pfisterer J,Reuss A,Friedlander M,Wilson MK,Kridelka F,Vergote I,Berek J,Dorigo O,Karam A,Bekkers RLM,Westermann A,Gatsonis C,Ng C,Herráez AC,Ottevanger N,Poveda A,Redondo A,Coleman R,Lu K,Gallardo-Rincón D,Gomez-Garcia E,Joly F,Leary A,Ray-Coquard I,Burger R,Moore KN,Fujiwara H,Hasegawa K,Gleeson N,Levy T,Rosengarten O,Katsumata N,Silverberg SG,Sugiyama T,Chang SJ,Kim BG,Nam BH,Colombo N,Ferrero A,Lorusso D,Scambia G,Edmondson R,McNeish I,Kohn E,Hirte H,McGee J,Provencher D,Sehouli J,Wimberger P,Maenpaa J,Mirza MR,Oza A,Welch S,Gaffney D,Small W,Glasspool R,Gourley C,Millan D,Zang R,Zhu (2017). Harmonising clinical trials within the Gynecologic Cancer InterGroup: Consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference. Annals of oncology, 28, viii30-viii35. (Read full publication)
    101. Sherertz T, Jhingran A, Biagioli M, Gaffney D, Elshaikh M, Coleman RL, Harkenrider M, Kidd EA, Jolly S, Yashar C, Portelance L, Wahl A, Venkatesan A, Li L, Small W Jr, American Radium Societ (2022). Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas. International journal of gynecological cancer, (Read full publication)
    102. Rock CB, Chipman JJ, Parsons MW, Weil CR, Hutten RJ, Tao R, Tward JD, Shah HR, Hu B, Stephens DM, Gaffney D (2022). Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy. Advances in radiation oncology, 7(6), 101035. (Read full publication)
    103. Fenlon JB, Hutten RJ, Johnson SB, Hu B, Shah H, Stephens DM, Maity A, Gaffney DK, Tao (2022). Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era. Leukemia & lymphoma, 64(2), 1-8. (Read full publication)
    104. Hu S, Baraghoshi D, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Peoples AR, Gaffney D, Hashibe (2022). Mental health disorders among ovarian cancer survivors in a population-based cohort. Cancer medicine, 12(2), 1801-1812. (Read full publication)
    105. Chang CP, Wilson CM, Rowe K, Snyder J, Dodson M, Deshmukh V, Newman M, Fraser A, Smith K, Date A, Stanford JB, Gaffney D, Mooney K, Hashibe (2022). Sexual dysfunction among gynecologic cancer survivors in a population-based cohort study. Supportive care in cancer, 31(1), 51. (Read full publication)
    106. Orio PF,Yashar C,Petereit D,Mourtada F,Klopp A,Gaffney D,Frank (2017). 2017 American Brachytherapy Society's Annual Meeting Report. Translational andrology and urology, 6(5), 1005-1013. (Read full publication)
    107. Parsons MW, Rock C, Chipman JJ, Shah HR, Hu B, Stephens DM, Tao R, Tward JD, Gaffney D (2023). Secondary malignancies in non-Hodgkin lymphoma survivors: 40¿years of follow-up assessed by treatment modality. Cancer medicine, 12(3), 2624-2636. (Read full publication)
    108. Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal (2023). Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 21(2), 181-209. (Read full publication)
    109. Kunz JN, Huang YJ, Casper AC, Suneja G, Burt LM, Jhingran A, Joyner MM, Harkenrider MM, Small W Jr, Grant JD, Kidd EA, Boucher K, Gaffney D (2023). Dosimetric Evaluation of OARs from SAVE Protocol. International journal of radiation oncology, biology, physics, (Read full publication)
    110. Mileshkin LR, Moore KN, Barnes EH, Gebski V, Narayan K, King MT, Bradshaw N, Lee YC, Diamante K, Fyles AW, Small W Jr, Gaffney DK, Khaw P, Brooks S, Thompson JS, Huh WK, Mathews CA, Buck M, Suder A, Lad TE, Barani IJ, Holschneider CH, Van Dyk S, Quinn M, Rischin D, Monk BJ, Stockler M (2023). Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial. The Lancet. Oncology, 24(5), 468-482. (Read full publication)
    111. Kunzman J, Hutten R, Kelley K, Harris K, Gaffney DK, DeCesaris C, Suneja G, Burt L (2023). Treatment patterns for leiomyosarcomas, endometrial stromal sarcomas and adenosarcomas: a national cancer database study. European Journal of Gynecological Oncology, 44(2), 25-31.
    112. Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N, Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committe (2023). FIGO staging of endometrial cancer: 2023. International journal of gynaecology and obstetrics, (Read full publication)
    113. Lee SS, Weil CR, Boyd LR, DeCesaris C, Gaffney D, Suneja (2023). Trends in use of radiation therapy, chemotherapy, and combination chemoradiotherapy in advanced uterine cancer before, during, and after GOG 258. International journal of gynecological cancer, 33(9), 1408-1418. (Read full publication)
    114. Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N, Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committe (2023). FIGO staging of endometrial cancer: 2023. Journal of gynecologic oncology, 34(5), e85. (Read full publication)
    115. Hutten RJ, Weil CR, King AJ, Barney B, Bylund CL, Fagerlin A, Gaffney DK, Gill D, Scherer L, Suneja G, Tward JD, Warner EL, Werner TL, Whipple G, Evans J, Johnson S (2023). Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine. JCO oncology practice, 19(11), OP2300179. (Read full publication)
    116. Huang YJ, DeCesaris CM, Sarkar V, Zhao H, Kunz J, Nelson G, Li X, Suneja G, Burt LM, Gaffney D (2023). Image-guided preplanning workflow for high-dose-rate interstitial brachytherapy for gynecological malignancies. Brachytherapy, 23(1), 25-34. (Read full publication)
    117. Ermann DA, Vardell VA, Shah H, Fitzgerald L, Tao R, Gaffney DK, Stephens DM, Hu (2023). Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy. Clinical lymphoma, myeloma & leukemia, 24(2), 94-104.e6. (Read full publication)
    118. Zhao H, Sarkar V, St James S, Paxton A, Su FF, Price RG, Dial C, Poppe M, Gaffney D, Salter (2024). Verification of surface-guided radiation therapy (SGRT) alignment for proton breast and chest wall patients by comparison to CT-on-rails and kV-2D alignment. Journal of applied clinical medical physics, 25(2), e14263. (Read full publication)
    119. Roach E, Hutten R, Johnson S, Suneja G, Tward J, Petereit D, Gaffney (2024). The impact of a positive COVID-19 test on timeliness of radiation in patients receiving brachytherapy. Brachytherapy, 23(3), 360-367. (Read full publication)
    120. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt L (2024). Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer. European journal of cancer (Oxford, England, 201, 113913. (Read full publication)
    121. Harari CM, Brower JV, Gaffney DK, Bradley K (2024). Navigating the Complexities of Lymph Node Management in Vulvar Cancer: Insights and Perspectives. Practical radiation oncology, (Read full publication)
    122. Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Holmes J, Howitt BE, Lea J, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian NR, Aggarwal S, Espinosa (2023). NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. Journal of the National Comprehensive Cancer Network, 21(12), 1224-1233. (Read full publication)
    123. Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R II, Glaser S, Holmes J, Howitt BE, Kendra K, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian N, Espinosa (2024). Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 22(2), 117-135. (Read full publication)
    124. Gaffney D, Suneja G, Weil C, Creutzberg (2024). FIGO Endometrial 2023 is better for radiation oncology patients. Practical radiation oncology, (Read full publication)
    125. DeCesaris C, Bedell S, Kelley K, Gaffney D, Suneja G, Burt L, Jarboe E, Brower (2024). Use of Radiation Therapy in the Management of Vulvar Cancers-Identification and Management of Acute and Late Toxicities. Practical radiation oncology, 15(1), e57-e62. (Read full publication)
    126. DeCesaris C, Wilson T, Kim J, Burt L, Grant J, Harkenrider MM, Huang J, Jhingran A, Kidd E, Konski A, Lin L, Small W Jr, Suneja G, Gaffney (2024). Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Practical radiation oncology, 14(6), e500-e506. (Read full publication)
    127. Creutzberg CL, Kim JW, Eminowicz G, Allanson E, Eberst L, Kim SI, Nout RA, Park JY, Lorusso D, Mileshkin L, Ottevanger PB, Brand A, Mezzanzanica D, Oza A, Gebski V, Pothuri B, Batley T, Gordon C, Mitra T, White H, Howitt B, Matias-Guiu X, Ray-Coquard I, Gaffney D, Small W Jr, Miller A, Concin N, Powell MA, Stuart G, Bookman MA, participants of the 2023 Gynecologic Cancer InterGroup Endometrial Cancer Consensus Conference on Clinical Researc (2024). Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup. The Lancet. Oncology, 25(9), e420-e431. (Read full publication)
    128. Burt L, Jarboe E, Gaffney D, Suneja G, DeCesaris C, Bedell S, Brower (2024). Vulvar Cancer: Histopathologic Considerations and Nuances to Management: Vulvar cancer considerations and nuances. Practical radiation oncology, 15(1), 86-92. (Read full publication)
    129. Kasera S,Weil CR,Wada D,Bowling M,Hu B,Gaffney DK,Maity A,Tao (2024). Ultra-low dose radiation therapy for primary cutaneous indolent B-cell lymphomas. JEADV clinical practice, 3(4), 1190-1194. (Read full publication)
    130. Ufkes NA,Tao R,Halwani AS,Miles R,Cipriano SD,Bowling M,Florell S,Gaffney D,Wada D (2024). Clinical spectrum of indolent mycosis fungoides with a gamma-delta (¿¿) phenotype: a single institution review including therapy and outcomes. JEADV clinical practice, (Read full publication)
    131. Fields EC, Bosch WR, Albuquerque KV, Bhatia R, Chino J, Dyer B, Erickson B, Fabian D, Gaffney D, Glaser S, Han K, Hathout L, Hsu IC, Jegadeesh N, Kahn J, Kidd E, Klopp A, Leung E, Lin L, Ludwig M, Ma T, Mell L, Mayadev J, Petersen I, Portelance L, Rash D, Taunk N, Viswanathan A, Wolfson A, Yashar C, Yeung A, Yoshida E, Fisher C (2024). Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity-Modulated Radiotherapy for Intact Cervical Cancer: An Update. Practical radiation oncology, 15(2), 171-179. (Read full publication)
    132. Martin T, Nelson G, Gaffney D, Dial C, Szegedi M, Rassiah (2025). Modified total skin electron treatment for a paraplegic patient. Journal of applied clinical medical physics, 26(7), e70162. (Read full publication)
    133. Chino J, Erickson B, Gaffney D, Hsu IC, Kamrava M, Kim Y, Niedermayr TR, Roumeliotis M, Rownd J, Todor D, Viswanathan A, Kidd E (2025). The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer. Brachytherapy, 24(4), 463-478. (Read full publication)
    134. DeCesaris C, Bedell S, Gaffney D, Suneja G, Burt L, Brower (2025). Identification and Management of Late toxicities after Radiotherapy for Vulvar Cancer. Practical radiation oncology, (Read full publication)
    135. Corrigan KL, Paulus R, Klopp AH, Wenzel LB, Yeung AR, Thompson JS, Doncals DE, Kundapur V, Wiggers NH, Mohan DS, Ghamande SA, Westin SN, Schnarr KL, Haas ML, Gaffney DK, Waggoner SE, Vanderwall PJ, Jastaniyah NT, Pugh SL, Kachnic L (2025). Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203. JCO oncology advances, 2(1), e2400088. (Read full publication)
    136. Poppe MM, Boucher K, Gaffney DK, Brownson KE, Smith G, Howell JN, Ticona FF, Kim J, Burt L, Cannon D, Kokeny (2025). NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation Therapy With a Simultaneous Lumpectomy Boost for Early-Stage Breast Cancer. International journal of radiation oncology, biology, physics, 123(1), 141-149. (Read full publication)
    137. Cruttenden J, Grant J, Evans J, Cannon G, Gaffney DK, Poppe M, Burt LM, Avizonis V, Boothe (2025). Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer. American journal of clinical oncology, 48(5), 222-229. (Read full publication)
    138. Howell JN, Mark B, Wada DA, Bowling M, Wei M, Lloyd SL, Gaffney DK, Maity A, LaRiviere MJ, Rule WG, Grant JD, Deshmukh V, Newman M, Date A, Hashibe M, Tao (2025). Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes. Cancer medicine, 14(5), e70577. (Read full publication)
    139. Cruttenden J, Weil C, Byer D, Burt L, Suneja G, Gaffney D, DeCesaris (2024). Patterns of Care in Adjuvant Radiation Therapy for Stage II Endometrioid Endometrial Adenocarcinoma: A National Cancer Database Analysis. Advances in radiation oncology, 10(2), 101698. (Read full publication)
    140. Hutten RJ, Fenlon JB, Kessel AC, Straessler KM, Huang YJ, Gaffney DK, Suneja G, Zempolich K, Burt L (2022). Radical trachelectomy and adjuvant vaginal brachytherapy to preserve fertility in pediatric cervical adenocarcinoma. Brachytherapy, 21(6), 764-768. (Read full publication)
    141. Abu-Rustum NR, Campos SM, Amarnath S, Arend R, Barber E, Bradley K, Brooks R, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Howitt BE, Landrum L, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Nieto K, Nwachukwu C, Podoll M, Rodabaugh K, Salani R, Schorge J, Schuetze S, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian N, Sambandam (2025). NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025. Journal of the National Comprehensive Cancer Network, 23(8), 284-291. (Read full publication)
    142. Weil CR, Brower J, Small W Jr, Gaffney DK, Klopp A (2025). Immunotherapy in the upfront definitive management of locally advanced cervical cancer: An evolving treatment paradigm. Practical radiation oncology, (Read full publication)

    Review

    1. Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes H (2013). ACR Appropriateness Criteria(R) management of locoregionally advanced squamous cell carcinoma of the vulva. American journal of clinical oncology, 36(4), 415-22. (Read full publication)
    2. Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney D (2013). Acr appropriateness Criteria management of vaginal cancer. Oncology (Williston Park, N.Y.), 27(11), 1166-73. (Read full publication)
    3. McCormack M, Gaffney D, Tan D, Bennet K, Chavez-Blanco A, Plante (2021). The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries. International journal of gynecological cancer, 31(5), 775-778. (Read full publication)
    4. Parsons MW,Huang YJ,Burt L,Suneja G,Gaffney (2022). Vaginal cuff brachytherapy for endometrial cancer: A review of major clinical trials with a focus on fractionation. International journal of gynecological cancer, 32(3), 311-315. (Read full publication)
    5. Huang YJ,Gaffney (2022). Brachytherapy: Common pitfalls. International journal of gynecological cancer, 32(3), 352-357. (Read full publication)
    6. Griffith T,Nwachukwu C,Albuquerque K,Gaffney (2022). The role for vaginal cuff brachytherapy boost after external beam radiation therapy in endometrial cancer. Brachytherapy, 21(2), 177-185. (Read full publication)
    7. Sagae S, Toita T, Matsuura M, Saito M, Matsuda T, Sato N, Shimizu A, Endo T, Fujii M, Gaffney DK, Small W J (2023). Improvement in radiation techniques for locally advanced cervical cancer during the last two decades. International journal of gynecological cancer, (Read full publication)
    8. Ladbury C, Harkenrider M, Taunk N, Fisher C, Mayadev J, Venkat P, Yashar C, Gaffney D, Beriwal S, Glaser (2023). A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer. Brachytherapy, (Read full publication)
    9. Ladbury C, Sueyoshi MH, Brovold NM, Kumar R, Andraos TY, Gogineni E, Kim M, Klopp A, Albuquerque K, Kunos C, Leung E, Mantz C, Biswas T, Beriwal S, Small W Jr, Erickson B, Gaffney D, Lo SS, Viswanathan A (2023). Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice Review. Practical radiation oncology, (Read full publication)
    10. Gaffney D, Matias-Guiu X, Mutch D, Scambia G, Creutzberg C, Fotopoulou C, Berek JS, Concin (2024). 2023 FIGO staging system for endometrial cancer: The evolution of the revolution. Gynecologic oncology, 184, 245-253. (Read full publication)
    11. Matias-Guiu X, Lax S, Raspollini MR, Palacios J, Zheng W, Liu C, de Brot L, Lordello L, Hardisson D, Gaffney D, Mutch D, Scambia G, Creutzberg CL, Fotopoulou C, Berek JS, Concin (2024). FIGO 2023 staging for endometrial cancer, when, if it is not now?. European journal of cancer (Oxford, England, 213, 115115. (Read full publication)
    12. Cun HT, Bedell SM, Kimball J, Gaffney DK, Hasan (2025). Radiation therapy for the gynecologic oncologist. Gynecologic oncology, 204, 79-90. (Read full publication)

    Book

    1. David K Gaffney, Dennis C Shrieve, Christopher J Anker, Mark K Buyyounouski, Feng-Ming Kong, Ying J Hitchcock, Jonathan D Tward (2012). Radiation Oncology: Imaging and Treatment.

    Book Chapter

    1. Anker CA, Gaffney D (2011). Ovary. 365-384.
    2. Gonzalez VJ, Gaffney D (2011). Vagina. 385-402.
    3. Ghia A, Gaffney D (2011). Radiotherapy for Vaginal and Vulvar Cancers.
    4. Jonathan D. Tward, Christopher J. Anker, David K. Gaffney and Glen M. Bowe (2012). Radiation Therapy and Skin Cancer.
    5. Mayer NA, Gaffney DK, Small (2011). Cervical Cancer (Ch. 22). 662-701.
    6. Orton AW, Gaffney D (2016). Radiotherapy for Vaginal Cancers.
    7. Boothe D, Gaffney D (2016). Radiotherapy for Vulvar Cancers.
    8. Renz M, Elkas JC, Gaffney (2025). Cervical and Vaginal Cancer (Ch. 38).

    Conference Proceedings

    1. Sagae S, Monk BJ, Pujade-Lauraine E, Gaffney DK, Narayan K, Ryu SY, McCormack M, Plante M, Casado A, Reuss A, Chávez-Blanco A, Kitchener H, Nam BH, Jhingran A, Temkin S, Mileshkin L, Berns E, Scholl S, Doll C, Abu-Rustum NR, Lecuru F, Small W Jr, Gynecologic Cancer InterGroup Cervix Cancer brainstorming day (2016). Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future. International journal of gynecological cancer, 26(1), 199-207. (Read full publication)
    2. Yeung AR,Deshmukh S,Klopp AH,Gil KM,Wenzel L,Westin SN,Konski AA,Gaffney DK,Small W,Thompson JS,Doncals DE,Cantuaria GHC,D'Souza DP,Chang A,Kundapur V,Mohan DS,Haas ML,Kim YB,Ferguson CL,Pugh SL,Kachnic LA,Bruner D (2022). Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared with Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial. Journal of clinical oncology, 40(27), 3115-3119. (Read full publication)

    Case Report

    1. Bagshaw HP, Williams NL, Huang YJ, Tward JD, Gaffney D (2015). Palladium interstitial implant in combination with external beam radiotherapy and chemotherapy for the definitive treatment of a female urethral carcinoma. Gynecologic oncology reports, 13, 40-3. (Read full publication)

    Editorial

    1. Gaffney D (2012). Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?. Journal of gynecologic oncology, 23(4), 207-9. (Read full publication)
    2. Hutten RJ, Huang YJ, Gaffney D (2021). Stereotactic body radiotherapy for the treatment of gynecologic malignancies: Passing fancy or here to stay?. Gynecologic oncology, 161(3), 642-644. (Read full publication)
    3. Dee EC, Eala MAB, Small W Jr, Gaffney DK, Tangco ED, Abdel-Wahab M, Grover (2022). Equity in Radiation Oncology Trials: from Knowledge Generation to Clinical Translation. International journal of radiation oncology, biology, physics, 113(3), 511-512. (Read full publication)
    4. Gaffney D,Creutzberg CL,Jhingran (2022). Special Issue: Radiation Oncology in Gynecologic Malignancies. International journal of gynecological cancer, 32(3), 215. (Read full publication)
    5. Cruttenden J, Balogun OD, Gaffney D, Suneja (2024). Destigmatizing gynecologic cancers and prioritizing prospective radiotherapy studies. Gynecologic oncology, 182, 121-123. (Read full publication)

    Letter

    1. Laggis CW,Lamb A,Secrest AM,Ufkes N,Halwani AS,Tao R,Gaffney D,Miles RR,Florell SR,Wada (2021). Favourable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single institution. Journal of the European Academy of Dermatology and Venereology, 35(1), e42-e45. (Read full publication)
    2. Tward JD,Shrieve DC,Gaffney D (2006). Author reply [2]. Cancer, 107(11), 2742. (Read full publication)
    3. Goldwein JW,Podmaniczky KC,Macklis RM,Patton GA,Gaffney DK,Moeller J (2003). Radiotherapeutic errors and computerized record/verify systems [1] (multiple letters). International journal of radiation oncology, biology, physics, 57(5), 1509-1510. (Read full publication)
    4. Mileshkin LR, Narayan K, Gaffney DK, Barnes EH, Lee YC, Monk BJ, Stockler M (2023). Adjuvant chemotherapy for locally advanced cervical cancer - Authors' reply. The Lancet. Oncology, 24(7), e290. (Read full publication)
    5. Burt L, Gaffney (2024). Take Your Best Shot Upfront!. International journal of radiation oncology, biology, physics, 118(2), 319-320. (Read full publication)
    6. Mutch D, Gaffney D, Matias-Guiu X, Fotopoulou C, Concin N, Berek JS, FIGO Endometrial Cancer Subcommitte (2024). Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification. International journal of gynaecology and obstetrics, (Read full publication)
    7. Concin N, Matias-Guiu X, Fotopoulou C, Creutzberg C, Mutch D, Gaffney D, Lindemann K, Kehoe S, Berek JS, FIGO Committee on Women's Cance (2024). Response: FIGO staging of endometrial cancer 2023. International journal of gynaecology and obstetrics, 164(1), 369-372. (Read full publication)

    Other

    1. Casper AC, Parsons MW, Chipman J, Burt LM Jr, Suneja G, Maurer KA, Gaffney D (2021). Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up. Gynecologic oncology, 162(2), 454-460. (Read full publication)
    2. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt L (2024). Corrigendum to "Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer" Eur. J. Cancer (201) (April) 2024, 113913. European journal of cancer (Oxford, England, 202, 114017. (Read full publication)

    Research Lab

    Lab link